Cite
Hermida-Prado F, Villaronga MÁ, Granda-Díaz R, et al. The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042. J Clin Med. 2019;8(8)doi: 10.3390/jcm8081157.
Hermida-Prado, F., Villaronga, M. �. �., Granda-Díaz, R., Del-Río-Ibisate, N., Santos, L., Hermosilla, M. A., Oro, P., Allonca, E., Agorreta, J., Garmendia, I., Tornín, J., Perez-Escuredo, J., Fuente, R., Montuenga, L. M., Morís, F., Rodrigo, J. P., Rodríguez, R., & García-Pedrero, J. M. (2019). The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042. Journal of clinical medicine, 8(8), . https://doi.org/10.3390/jcm8081157
Hermida-Prado, Francisco, et al. "The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042." Journal of clinical medicine vol. 8,8 (2019). doi: https://doi.org/10.3390/jcm8081157
Hermida-Prado F, Villaronga MÁ, Granda-Díaz R, Del-Río-Ibisate N, Santos L, Hermosilla MA, Oro P, Allonca E, Agorreta J, Garmendia I, Tornín J, Perez-Escuredo J, Fuente R, Montuenga LM, Morís F, Rodrigo JP, Rodríguez R, García-Pedrero JM. The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042. J Clin Med. 2019 Aug 02;8(8). doi: 10.3390/jcm8081157. PMID: 31382448; PMCID: PMC6722627.
Copy
Download .nbib